Cite

HARVARD Citation

    Anton, A. et al. (n.d.). 223PUsing PSMA PET/CT to assess response in metastatic prostate cancer (mPC) patients (pts) receiving upfront chemohormonal therapy. Annals of oncology. p. . [Online]. 
  
Back to record